Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
- 2021-05
- Infectious Diseases Now 51(3)
- A. Poncelet
- L. Ruelle
- D. Konopnicki
- V. Y. Miendje Deyi
- N. Dauby
- PubMed: 33934809
- DOI: 10.1016/j.idnow.2020.12.003
- Low evidence
S. cerevisiae fungemia is a rare but life-threatening infection, associated with intake of probiotics containing S. boulardii. ... Mortality rate was 50%.
- Effect
- Harmful
- Effect size
- Large